Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001209191-23-048199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-09-01 | ACRS | Balthaser Kevin | CFO | F - Tax | $7.90 | -285 | 5,971 | -5% | -$2,252 |
| D | 2023-09-05 | 2023-09-01 | ACRS | Balthaser Kevin | CFO | M - OptEx | — | +1,000 | 6,256 | +19% | — |
| D | 2023-09-05 | 2023-09-01 | ACRS | Balthaser Kevin | CFO | M - OptEx | $0.00 | -1,000 | 1,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | F | D | 285 | $7.90 | 5,971 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | M | A | 1,000 | — | 6,256 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 3 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 1,000 | $0.00 | 1,000 | D | — · — to — | 1,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F3) The shares underlying these restricted stock units vest over a period of two years, with one-half of the shares vesting on each of September 1, 2023 and September 1, 2024, subject to the reporting person's continuous service with the issuer as of the applicable vesting date. |